Carine Claeys

GlaxoSmithKline (Belgium) — Belgium

Medicine · Health Sciences

14h-index1.3kcitations46works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(17), Occupational and environmental lung diseases(14), Respiratory viral infections research(12), Immune Response and Inflammation(5), Pneumonia and Respiratory Infections(3)

Publications45 total

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Nature Medicine·2020· 342 citedOpen Access
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
npj Vaccines·2019· 30 citedOpen Access
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons
The Pediatric Infectious Disease Journal·2019· 43 citedOpen Access
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
The Lancet Infectious Diseases·2019· 138 citedOpen Access
Clinical Presentation of Influenza in Children 6 to 35 Months of Age
The Pediatric Infectious Disease Journal·2019· 18 cited
Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children
The Pediatric Infectious Disease Journal·2018· 4 citedOpen Access
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
BMC Infectious Diseases·2018· 9 citedOpen Access
Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons
The Lancet Child & Adolescent Health·2018· 76 cited
Additional file 1: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
Figshare·2018Open Access
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
The Journal of Infectious Diseases·2017· 76 citedOpen Access
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
Human Vaccines & Immunotherapeutics·2017· 55 citedOpen Access
INACTIVATED QUADRIVALENT INFLUENZA VACCINE PREVENTS DISEASE DUE TO MATCHED AND MISMATCHED STRAINS: A RANDOMISED TRIAL IN CHILDREN AGED 6–35 MONTHS DURING 2011–2014
2017· 2 cited
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and <i>post-hoc</i> correlate of protection analysis
Human Vaccines & Immunotherapeutics·2016· 10 citedOpen Access
Randomized, Phase III Clinical Trial to Assess the Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine Co-Administered With a Seasonal Quadrivalent-Inactivated Influenza Vaccine in Adults Aged 50 Years and Older
Open Forum Infectious Diseases·2016· 4 citedOpen Access
Immunogenicity and Safety Profiles of Full (0.5 mL) Compared to Half (0.25 mL) Dose-Inactivated Influenza Vaccines in Children 6–35 Months Old
Open Forum Infectious Diseases·2015Open Access
Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
The Pediatric Infectious Disease Journal·2014· 18 cited
Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older
BMC Infectious Diseases·2014· 41 citedOpen Access
N-09: Immunogénicité et tolérance d’un vaccin antigrippal quadrivalent inactivé chez l’adulte : étude randomisée contrôlée
Médecine et Maladies Infectieuses·2014
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
BMC Infectious Diseases·2013· 103 citedOpen Access
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
The Lancet Infectious Diseases·2013· 161 cited
page 1 of 3Next →

Frequent Co-authors

Bruce L. Innis(17), Varsha Jain(12), José García-Sicilia(7), Federico Martinón‐Torres(7), E Quinot(6), E Balgairies(6), Lidia Oostvogels(5), Khalequ Zaman(5), Ping Li(5), Javier Díez‐Domingo(5), Saul N. Faust(5), Roman Prymula(5), Iwona Sadowska-Krawczenko(5), Henryk Szymański(5), Alfonso Carmona(5), Ghassan Dbaibo(4), Allen Izu(4), Pope Kosalaraksa(4), Maria Basanta(4), Luis Cousin(4)